Cargando…
Discovery of novel brain permeable and G protein-biased beta-1 adrenergic receptor partial agonists for the treatment of neurocognitive disorders
The beta-1 adrenergic receptor (ADRB1) is a promising therapeutic target intrinsically involved in the cognitive deficits and pathological features associated with Alzheimer’s disease (AD). Evidence indicates that ADRB1 plays an important role in regulating neuroinflammatory processes, and activatio...
Autores principales: | Yi, Bitna, Jahangir, Alam, Evans, Andrew K., Briggs, Denise, Ravina, Kristine, Ernest, Jacqueline, Farimani, Amir B., Sun, Wenchao, Rajadas, Jayakumar, Green, Michael, Feinberg, Evan N., Pande, Vijay S., Shamloo, Mehrdad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5529018/ https://www.ncbi.nlm.nih.gov/pubmed/28746336 http://dx.doi.org/10.1371/journal.pone.0180319 |
Ejemplares similares
-
β1-adrenergic receptor activation enhances memory in Alzheimer's disease model
por: Coutellier, Laurence, et al.
Publicado: (2014) -
Beta-Adrenergic Agonists
por: Barisione, Giovanni, et al.
Publicado: (2010) -
Role of Endoplasmic Reticulum Stress in Learning and Memory Impairment and Alzheimer's Disease-Like Neuropathology in the PS19 and APP(Swe) Mouse Models of Tauopathy and Amyloidosis
por: Briggs, Denise Isabelle, et al.
Publicado: (2017) -
Intracerebral Delivery of Brain-Derived Neurotrophic Factor Using HyStem(®)-C Hydrogel Implants Improves Functional Recovery and Reduces Neuroinflammation in a Rat Model of Ischemic Stroke
por: Ravina, Kristine, et al.
Publicado: (2018) -
Simulations of Biased Agonists in the β(2) Adrenergic Receptor with Accelerated Molecular Dynamics
por: Tikhonova, Irina G., et al.
Publicado: (2013)